Litigation Details for In Re: Akorn, Inc. Data Integrity Securities Litigation (N.D. Ill. 2018)
✉ Email this page to a colleague
In Re: Akorn, Inc. Data Integrity Securities Litigation (N.D. Ill. 2018)
Docket | ⤷ Subscribe | Date Filed | 2018-03-08 |
Court | District Court, N.D. Illinois | Date Terminated | 2020-03-13 |
Cause | 15:78m(a) Securities Exchange Act | Assigned To | Steven C. Seeger |
Jury Demand | Both | Referred To | |
Patents | 8,178,541 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in In Re: Akorn, Inc. Data Integrity Securities Litigation
Details for In Re: Akorn, Inc. Data Integrity Securities Litigation (N.D. Ill. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2019-07-05 | 116 | Exhibit A | 6.43 1/15/2019 8,178,541 125,492,373 6.52 … 11/29/2016 Akorn Invalidates Durezol(R) Patent Via Inter Partes Review Proceeding … Press Release: Akorn Invalidates Durezol(R) Patent Via Inter Partes Review Proceeding …Allergan Partners With Indian Tribe to Protect Drug Patents …Allergan Partners With Indian Tribe to Protect Drug Patents | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |